Skip to Content
Merck
All Photos(3)

Documents

P4019

Sigma-Aldrich

Brij® S20

Synonym(s):

Polyethylene glycol octadecyl ether, Polyoxyethylene (20) stearyl ether

Sign Into View Organizational & Contract Pricing
All Photos(3)

About This Item

Linear Formula:
C18H37(OCH2CH2)nOH, n~20
CAS Number:
9005-00-9
MDL number:
MFCD00074177
UNSPSC Code:
12162002
PubChem Substance ID:
24898482
NACRES:
NA.23

form

solid

Quality Level

100

mp

44-46 °C (lit.)

HLB

15

SMILES string

CCCCCCCCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO

InChI

1S/C20H41O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-19-22-20-18-21/h2-20H2,1H3

InChI key

PSEGVHKUPXNGGJ-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Related Categories

General description

Brij® S20 is a surfactant that belongs to the class of polyoxyethylene ethers. It is majorly used in pharmaceutical applications to improve the solubility of the drugs. It can also be grafted on a variety of surfaces to enhance the intracellular uptake of dyes.

Application


  • Nanostructured lipid carriers for oral delivery of silymarin: Improving its absorption and in vivo efficacy in type 2 diabetes and metabolic syndrome model.: This study utilizes Brij® S20 to develop nanostructured lipid carriers for oral delivery of silymarin. The findings demonstrate enhanced absorption and efficacy of silymarin in treating type 2 diabetes and metabolic syndrome, highlighting the potential of Brij® S20 in improving drug delivery systems. (Piazzini et al., 2019).

  • Water-stable all-biodegradable microparticles in nanofibers by electrospinning of aqueous dispersions for biotechnical plant protection.: The study uses Brij® S20 to create water-stable, biodegradable microparticles in nanofibers through electrospinning. These microparticles are designed for biotechnical plant protection, demonstrating the potential of Brij® S20 in agricultural biotechnology. (Bansal et al., 2012).


Legal Information

Brij is a registered trademark of Croda International PLC

comparable product

Product No.
Description
Pricing

STS0218

ECO Brij® S20

Pictograms

Exclamation mark
GHS07

Signal Word

Warning

Hazard Statements

H302

Precautionary Statements

P264 - P270 - P301 + P312 - P501

Hazard Classifications

Acute Tox. 4 Oral

Storage Class Code

11 - Combustible Solids

WGK

WGK 2

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Customers Also Viewed

Slide 1 of 2

1 of 2

Brij® O10

Sigma-Aldrich

P6136

Brij® O10

MERPOL® HCS surfactant

Sigma-Aldrich

421308

MERPOL® HCS surfactant

Nanostructured lipid carriers as promising delivery systems for plant extracts: The case of silymarin
Piazzini V, et al.
Applied Sciences, 8(7), 1163-1163 (2018)
Brij-grafted-chitosan copolymers with function of P-glycoprotein modulation: Synthesis, characterization and in vitro investigations
Xiong W, et al.
Carbohydrate Polymers, 204, 89-96 (2019)
Wei Xiong et al.
International journal of nanomedicine, 13, 3781-3793 (2018-07-11)
Berberine (BBR) is a plant-derived benzylisoquinoline alkaloid and has been demonstrated to be a potential treatment for various chronic diseases. The poor water solubility and P-glycoprotein (Pgp)-mediated drug efflux are the main challenges for its further application in a clinical
Jae-Haeng Song et al.
Drug development and industrial pharmacy, 35(8), 897-903 (2009-02-26)
The oral administration of loratadine, an antihistamine, can have a variety of adverse side effects, such as headache, fatigue, and nausea, because of the transient high blood concentration. To avoid these effects, loratadine can be administered using a transdermal drug
S O Williams et al.
Drug development and industrial pharmacy, 26(1), 71-77 (2000-04-01)
The purpose of this study was to scale up an oil/water (o/w) cream formulation containing 40% diethylene glycol monoethyl ether (DGME), developed via 300-g laboratory batches in a 2(5-2) fractional factorial design, to 7-kg batch sizes in a Brogli-10 homogenizer.
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service